price
SP
OTC · SPHRY
Starpharma Holdings Limited
Healthcare · Biotechnology
$2.82
Down-$0.43 (-13.23%)
Updated Nov 3, 2026, 3:26 PM
SID Score
5.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 108.27M
- P/E ratio
- -15.28
- Dividend yield
- 2.98%
- 52-week range
- $0.47 – $3.60
- Volume
- 1.04K
- Avg. volume
- 1.71K
Price performance · SPHRY
SPHRY price history
1M range · 0 trading sessions · Daily adjusted prices
SPHRY does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
Latest SPHRY news
The latest Smart Investors Daily articles mentioning SPHRY.
Stock researchCompany · Overview
Company
Market Activity
Research & News
SPHRY research
Overview
Company profile and research snapshot.
Company profile
STARPHARMA HLDGS S/ADR
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $2.76
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 31, 2022 | BELL POTTER SECURITIES | Buy | — |
| Oct 31, 2022 | BELL POTTER SECURITIES | Buy | — |
| Oct 30, 2022 | BELL POTTER SECURITIES | Buy | — |
| Sep 30, 2021 | BELL POTTER SECURITIES | Buy | — |
| Sep 30, 2021 | BELL POTTER SECURITIES | Buy | — |
News briefing
No generated briefing is available yet.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.